

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Well, thanks to some encouraging ruckus in the last few months, you may actually have heard of TTIP: the anodynely-acronymed "Transatlantic Trade and Investment Partnership".
Well, thanks to some encouraging ruckus in the last few months, you may actually have heard of TTIP: the anodynely-acronymed "Transatlantic Trade and Investment Partnership". In plain English, it's a massive trade deal between the EU and North America which could affect everything from healthcare choices to government banking regulations to the air we breathe. (And it gets better, TPP is the US-Asia Pacific counterpart.)
Activists and even some politicians have been up in arms about one particularly nasty element of these behemoths, which together will cover almost 50 percent of global GDP. That element is the proposed secret courts where, in theory, oil companies could sue governments who try to bring in green-friendly policies, tobacco companies could challenge advertising restrictions, and private healthcare providers could pick apart what's left of national health services. To name a few.
But in truth, we just don't know what TTIP will mean because the negotiations are happening in secret. And the European Commission has just made a mockery of its own European Citizens' Initiative, whereby citizens are supposed to be able to register dissent, by refusing to "allow" that dissent to be registered. (This in fact could prove a spectacular own goal because, in making it so plain that this supposedly-democratic mechanism is toothless, it paves the way for a challenge in the courts.)
What we do know, however, are the lessons from recent history. As Saskia Sassen, who has looked at this question for decades, points out: time and again, when global corporations gain rights through free trade deals, citizens lose out-in large part through a negative boomerang effect of job losses and wage stagnation that cheaper goods just don't compensate for.
We also know that it's farcical of the European Commission to try and claim that Europe's citizens cannot have a say in this process because the treaty will have "no legal effect" on citizens. Grist to the mill of UKIP and others, as if they needed it.
Exposing and challenging this unaccountable "Nafta on steroids" is just what openDemocracy was made for. And here is where we're doing it. See what Frances O'Grady, head of the TUC; Saskia Sassen at Columbia University and John Hilary of War on Want have to say about it, along with many others, and join the debate.
Ebola, on the other hand, is something it's now hard to avoid hearing about. In the US, the main news channels have finally arrived (catastrophically late) to the party, churning out hourly updates of the isolated number of suspected cases on home soil.
And yet, in the blanket coverage, key points are being missed. Back in August openSecurity published this piece by Bob Rigg which addresses the fundamental question: why have we failed for decades to develop a vaccine for an Ebola? The answer is not to do with science, but with abject market failures and the searing inequities of our world.
Inequities also account for the startling and under-reported fact that 75% of those infected by Ebola in Liberia have been women. Why? Because women fulfil the traditional role of caregivers, that's part of it and it speaks volumes. But there's also anecdotal evidence to suggest something even more sinister and calculated at play-that some men might exploit this tradition to keep themselves out of harm's way. Writing for 50.50 from Abuja, Tooni Akuni makes the rather obvious yet so far largely ignored point that, based on the numbers alone, women must be included in strategies to assess the scope of the outbreak, in designing responses and in implementing interventions.
It now appears inevitable that the Ebola outbreak is going to get worse before it gets better. With over 10,000 infected to date, this is a devastating prognosis. But within that tragedy, there are also thousands of stories of bravery and selflessness. Transformation has published this interview with former child soldier B. Abel Learwellie who, having lost nearly all his family to the disease, is now risking his own life to help treat others. And at Avaaz.org, on this page alone, nearly 4,000 people with badly-needed medical and logistical skills have already signed up to travel to west Africa and risk their lives for people they have never met.
Reading their reasons for doing so, written in scores of languages, offers more than a sliver of hope for humanity. As Nelson Mandela once said, "Courage is not the absence of fear, but the triumph over it." B. Abel Learwellie and thousands of others across the world are now living this. We must bear witness to their bravery as well as to all the injustice which has made it necessary.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Well, thanks to some encouraging ruckus in the last few months, you may actually have heard of TTIP: the anodynely-acronymed "Transatlantic Trade and Investment Partnership". In plain English, it's a massive trade deal between the EU and North America which could affect everything from healthcare choices to government banking regulations to the air we breathe. (And it gets better, TPP is the US-Asia Pacific counterpart.)
Activists and even some politicians have been up in arms about one particularly nasty element of these behemoths, which together will cover almost 50 percent of global GDP. That element is the proposed secret courts where, in theory, oil companies could sue governments who try to bring in green-friendly policies, tobacco companies could challenge advertising restrictions, and private healthcare providers could pick apart what's left of national health services. To name a few.
But in truth, we just don't know what TTIP will mean because the negotiations are happening in secret. And the European Commission has just made a mockery of its own European Citizens' Initiative, whereby citizens are supposed to be able to register dissent, by refusing to "allow" that dissent to be registered. (This in fact could prove a spectacular own goal because, in making it so plain that this supposedly-democratic mechanism is toothless, it paves the way for a challenge in the courts.)
What we do know, however, are the lessons from recent history. As Saskia Sassen, who has looked at this question for decades, points out: time and again, when global corporations gain rights through free trade deals, citizens lose out-in large part through a negative boomerang effect of job losses and wage stagnation that cheaper goods just don't compensate for.
We also know that it's farcical of the European Commission to try and claim that Europe's citizens cannot have a say in this process because the treaty will have "no legal effect" on citizens. Grist to the mill of UKIP and others, as if they needed it.
Exposing and challenging this unaccountable "Nafta on steroids" is just what openDemocracy was made for. And here is where we're doing it. See what Frances O'Grady, head of the TUC; Saskia Sassen at Columbia University and John Hilary of War on Want have to say about it, along with many others, and join the debate.
Ebola, on the other hand, is something it's now hard to avoid hearing about. In the US, the main news channels have finally arrived (catastrophically late) to the party, churning out hourly updates of the isolated number of suspected cases on home soil.
And yet, in the blanket coverage, key points are being missed. Back in August openSecurity published this piece by Bob Rigg which addresses the fundamental question: why have we failed for decades to develop a vaccine for an Ebola? The answer is not to do with science, but with abject market failures and the searing inequities of our world.
Inequities also account for the startling and under-reported fact that 75% of those infected by Ebola in Liberia have been women. Why? Because women fulfil the traditional role of caregivers, that's part of it and it speaks volumes. But there's also anecdotal evidence to suggest something even more sinister and calculated at play-that some men might exploit this tradition to keep themselves out of harm's way. Writing for 50.50 from Abuja, Tooni Akuni makes the rather obvious yet so far largely ignored point that, based on the numbers alone, women must be included in strategies to assess the scope of the outbreak, in designing responses and in implementing interventions.
It now appears inevitable that the Ebola outbreak is going to get worse before it gets better. With over 10,000 infected to date, this is a devastating prognosis. But within that tragedy, there are also thousands of stories of bravery and selflessness. Transformation has published this interview with former child soldier B. Abel Learwellie who, having lost nearly all his family to the disease, is now risking his own life to help treat others. And at Avaaz.org, on this page alone, nearly 4,000 people with badly-needed medical and logistical skills have already signed up to travel to west Africa and risk their lives for people they have never met.
Reading their reasons for doing so, written in scores of languages, offers more than a sliver of hope for humanity. As Nelson Mandela once said, "Courage is not the absence of fear, but the triumph over it." B. Abel Learwellie and thousands of others across the world are now living this. We must bear witness to their bravery as well as to all the injustice which has made it necessary.
Well, thanks to some encouraging ruckus in the last few months, you may actually have heard of TTIP: the anodynely-acronymed "Transatlantic Trade and Investment Partnership". In plain English, it's a massive trade deal between the EU and North America which could affect everything from healthcare choices to government banking regulations to the air we breathe. (And it gets better, TPP is the US-Asia Pacific counterpart.)
Activists and even some politicians have been up in arms about one particularly nasty element of these behemoths, which together will cover almost 50 percent of global GDP. That element is the proposed secret courts where, in theory, oil companies could sue governments who try to bring in green-friendly policies, tobacco companies could challenge advertising restrictions, and private healthcare providers could pick apart what's left of national health services. To name a few.
But in truth, we just don't know what TTIP will mean because the negotiations are happening in secret. And the European Commission has just made a mockery of its own European Citizens' Initiative, whereby citizens are supposed to be able to register dissent, by refusing to "allow" that dissent to be registered. (This in fact could prove a spectacular own goal because, in making it so plain that this supposedly-democratic mechanism is toothless, it paves the way for a challenge in the courts.)
What we do know, however, are the lessons from recent history. As Saskia Sassen, who has looked at this question for decades, points out: time and again, when global corporations gain rights through free trade deals, citizens lose out-in large part through a negative boomerang effect of job losses and wage stagnation that cheaper goods just don't compensate for.
We also know that it's farcical of the European Commission to try and claim that Europe's citizens cannot have a say in this process because the treaty will have "no legal effect" on citizens. Grist to the mill of UKIP and others, as if they needed it.
Exposing and challenging this unaccountable "Nafta on steroids" is just what openDemocracy was made for. And here is where we're doing it. See what Frances O'Grady, head of the TUC; Saskia Sassen at Columbia University and John Hilary of War on Want have to say about it, along with many others, and join the debate.
Ebola, on the other hand, is something it's now hard to avoid hearing about. In the US, the main news channels have finally arrived (catastrophically late) to the party, churning out hourly updates of the isolated number of suspected cases on home soil.
And yet, in the blanket coverage, key points are being missed. Back in August openSecurity published this piece by Bob Rigg which addresses the fundamental question: why have we failed for decades to develop a vaccine for an Ebola? The answer is not to do with science, but with abject market failures and the searing inequities of our world.
Inequities also account for the startling and under-reported fact that 75% of those infected by Ebola in Liberia have been women. Why? Because women fulfil the traditional role of caregivers, that's part of it and it speaks volumes. But there's also anecdotal evidence to suggest something even more sinister and calculated at play-that some men might exploit this tradition to keep themselves out of harm's way. Writing for 50.50 from Abuja, Tooni Akuni makes the rather obvious yet so far largely ignored point that, based on the numbers alone, women must be included in strategies to assess the scope of the outbreak, in designing responses and in implementing interventions.
It now appears inevitable that the Ebola outbreak is going to get worse before it gets better. With over 10,000 infected to date, this is a devastating prognosis. But within that tragedy, there are also thousands of stories of bravery and selflessness. Transformation has published this interview with former child soldier B. Abel Learwellie who, having lost nearly all his family to the disease, is now risking his own life to help treat others. And at Avaaz.org, on this page alone, nearly 4,000 people with badly-needed medical and logistical skills have already signed up to travel to west Africa and risk their lives for people they have never met.
Reading their reasons for doing so, written in scores of languages, offers more than a sliver of hope for humanity. As Nelson Mandela once said, "Courage is not the absence of fear, but the triumph over it." B. Abel Learwellie and thousands of others across the world are now living this. We must bear witness to their bravery as well as to all the injustice which has made it necessary.